Reproductive Biology and Endocrinology (May 2011)

Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?

  • Verheyen Greta,
  • Camus Michel,
  • Van den Abbeel Etienne,
  • Van Landuyt Lisbet,
  • Stoop Dominic,
  • Devroey Paul

DOI
https://doi.org/10.1186/1477-7827-9-60
Journal volume & issue
Vol. 9, no. 1
p. 60

Abstract

Read online

Abstract Background Single blastocyst transfer has the advantage of maximizing the fresh single pregnancy rate. However, in patients with a low number of good quality embryos on day 3, it remains unclear whether immediate embryo transfer or further embryo culture with blastocyst transfer is the most preferable option. Methods A retrospective cohort study was carried out in which the outcome of 590 fresh in vitro fertilization (IVF) cycles over a 15 months period and their cryo cycles were analyzed. A total of 341 patients cycles had an elective day 5 strategy independent of intermediate embryo evaluation while another 249 patients underwent a day 5 embryo transfer only if at least four embryos were available on day 3. Blastocyst vitrification was performed using a closed high security system. Results Demographics, stimulation parameters and embryological data were comparable in the two groups. Patients in the elective day 5 group had a lower fresh transfer rate (90.62% vs. 95.18%, p Conclusions Despite lower fresh transfer rates, elective single blastocyst transfer yields a similar projected cumulative ongoing pregnancy rate as in a policy with cleavage stage or blastocyst transfer depending on a good quality embryo count on day 3.